9539

    0

    SAKAR

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    SAKAR HEALTHCARE LIMITED Share Price Today

    SAKAR HEALTHCARE LIMITED is currently trading at ₹919.7, up by ₹29.0 from the previous close. The stock touched an intraday high of ₹937.00 and a low of ₹895.60 during the latest trading session. Over the past one year, SAKAR HEALTHCARE LIMITED has delivered a return of 162.74%, while the stock has gained 6.67% in the last one month.

    SAKAR HEALTHCARE LIMITED performance

    Today’s low Today’s high
    ₹ 895.60 ₹ 937.00
    ₹ 919.95
    52 week low 52 week high
    ₹ 311.00 ₹ 960.00
    ₹ 919.95
    Open Price ₹ 899.95
    Prev. Close ₹ 890.70
    Volume (Shares) 120333.00
    Total traded value ₹ 1107.00
    Upper Circuit ₹ 979.75
    Lower Circuit ₹ 801.65
    info

    Investment Returns

    Over 1 Month 6.67% Over 3 Months 41.45% Over 6 Months 104.87% Over 1 Year 162.74%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    SAKAR HEALTHCARE LIMITED fundamentals


    • Market cap (Cr) 2,046.90
    • P/E Ratio (TTM) 54.91
    • Beta 0.72
    • Book Value / share 145.86
    • Return on equity 6.39%
    • EPS (TTM) 16.22
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 10.28
    info icon alternate text
    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) [-]
    info icon alternate text

    SAKAR HEALTHCARE LIMITED Financials

    Open financial information
    Revenue
    Net income
    Particulars JUN 2026 (Values in Cr)
    Revenue 72.97
    Operating Expense 59.94
    Net Profit 10.28
    Net Profit Margin (%) 14.08
    Earnings Per Share (EPS) 4.62
    EBITDA 22.79
    Effective Tax Rate (%) 29.49
    Particulars MAR 2026 (Values in Cr)
    Revenue 71.10
    Operating Expense 53.20
    Net Profit 11.02
    Net Profit Margin (%) 15.49
    Earnings Per Share (EPS) 4.96
    EBITDA 26.41
    Effective Tax Rate (%) 38.98
    Particulars DEC 2025 (Values in Cr)
    Revenue 70.34
    Operating Expense 59.90
    Net Profit 10.25
    Net Profit Margin (%) 14.57
    Earnings Per Share (EPS) 4.59
    EBITDA 19.09
    Effective Tax Rate (%) 6.39
    Particulars SEP 2025 (Values in Cr)
    Revenue 57.56
    Operating Expense 53.42
    Net Profit 4.54
    Net Profit Margin (%) 7.88
    Earnings Per Share (EPS) 2.03
    EBITDA 12.57
    Effective Tax Rate (%) 15.29
    Particulars JUN 2025 (Values in Cr)
    Revenue 52.74
    Operating Expense 47.74
    Net Profit 4.67
    Net Profit Margin (%) 8.85
    Earnings Per Share (EPS) 2.11
    EBITDA 13.09
    Effective Tax Rate (%) 13.19
    Particulars MAR 2026 (Values in Cr)
    Revenue 251.74
    Operating Expense 214.27
    Net Profit 30.48
    Net Profit Margin (%) 12.10
    Earnings Per Share (EPS) 13.70
    EBITDA 71.17
    Effective Tax Rate (%) 23.31
    Particulars MAR 2025 (Values in Cr)
    Revenue 177.58
    Operating Expense 157.32
    Net Profit 17.50
    Net Profit Margin (%) 9.85
    Earnings Per Share (EPS) 7.97
    EBITDA 50.95
    Effective Tax Rate (%) 18.71
    Particulars MAR 2024 (Values in Cr)
    Revenue 153.35
    Operating Expense 140.63
    Net Profit 11.67
    Net Profit Margin (%) 7.61
    Earnings Per Share (EPS) 5.64
    EBITDA 41.54
    Effective Tax Rate (%) 26.60
    Particulars MAR 2023 (Values in Cr)
    Revenue 133.36
    Operating Expense 121.15
    Net Profit 12.76
    Net Profit Margin (%) 9.56
    Earnings Per Share (EPS) 6.58
    EBITDA 37.82
    Effective Tax Rate (%) 24.40
    Particulars MAR 2022 (Values in Cr)
    Revenue 128.23
    Operating Expense 111.39
    Net Profit 15.24
    Net Profit Margin (%) 11.88
    Earnings Per Share (EPS) 8.77
    EBITDA 31.58
    Effective Tax Rate (%) 19.83
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 128.75
    ROE % 6.39
    ROCE % 8.37
    Total Debt to Total Equity 0.30
    EBITDA Margin 28.69
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 118.41
    ROE % 5.36
    ROCE % 7.36
    Total Debt to Total Equity 0.46
    EBITDA Margin 27.09
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 91.04
    ROE % 8.48
    ROCE % 8.85
    Total Debt to Total Equity 0.70
    EBITDA Margin 28.35
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 74.45
    ROE % 13.49
    ROCE % 12.05
    Total Debt to Total Equity 0.60
    EBITDA Margin 24.63
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 63.04
    ROE % 11.88
    ROCE % 13.07
    Total Debt to Total Equity 0.33
    EBITDA Margin 25.09
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 128.78
    ROE % 6.39
    ROCE % 8.37
    Total Debt to Total Equity 0.30
    EBITDA Margin 28.69
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 118.44
    ROE % 5.36
    ROCE % 7.36
    Total Debt to Total Equity 0.46
    EBITDA Margin 27.09
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 91.09
    ROE % 8.48
    ROCE % 8.85
    Total Debt to Total Equity 0.70
    EBITDA Margin 28.35
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 74.50
    ROE % 13.49
    ROCE % 12.05
    Total Debt to Total Equity 0.60
    EBITDA Margin 24.63
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 63.04
    ROE % 11.89
    ROCE % 13.07
    Total Debt to Total Equity 0.33
    EBITDA Margin 25.10
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.30
    Total Assets 415.26
    Total Liabilities 415.26
    Total Equity 285.47
    Share Outstanding 2
    Price to Book Ratio 1.64
    Return on Assets (%) 4.21
    Return on Capital (%) 4.86
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.46
    Total Assets 388.65
    Total Liabilities 388.65
    Total Equity 262.33
    Share Outstanding 2
    Price to Book Ratio 3.11
    Return on Assets (%) 3.00
    Return on Capital (%) 3.52
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.09
    Total Assets 336.33
    Total Liabilities 336.33
    Total Equity 173.34
    Share Outstanding 1
    Price to Book Ratio 2.20
    Return on Assets (%) 3.79
    Return on Capital (%) 4.48
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.02
    Total Assets 267.76
    Total Liabilities 267.76
    Total Equity 127.45
    Share Outstanding 1
    Price to Book Ratio 1.81
    Return on Assets (%) 5.69
    Return on Capital (%) 7.02
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.08
    Total Assets 177.79
    Total Liabilities 177.79
    Total Equity 98.45
    Share Outstanding 1
    Price to Book Ratio 1.79
    Return on Assets (%) 6.00
    Return on Capital (%) 7.71
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.30
    Total Assets 415.34
    Total Liabilities 415.34
    Total Equity 285.56
    Share Outstanding 2
    Price to Book Ratio 1.64
    Return on Assets (%) 4.21
    Return on Capital (%) 4.85
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.46
    Total Assets 388.74
    Total Liabilities 388.74
    Total Equity 262.41
    Share Outstanding 2
    Price to Book Ratio 3.11
    Return on Assets (%) 3.00
    Return on Capital (%) 3.52
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.09
    Total Assets 336.42
    Total Liabilities 336.42
    Total Equity 173.43
    Share Outstanding 1
    Price to Book Ratio 2.20
    Return on Assets (%) 3.79
    Return on Capital (%) 4.48
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.02
    Total Assets 267.84
    Total Liabilities 267.84
    Total Equity 127.53
    Share Outstanding 1
    Price to Book Ratio 1.81
    Return on Assets (%) 5.69
    Return on Capital (%) 7.02
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.08
    Total Assets 177.80
    Total Liabilities 177.80
    Total Equity 98.46
    Share Outstanding 1
    Price to Book Ratio 1.79
    Return on Assets (%) 6.01
    Return on Capital (%) 7.71
    Particulars MAR 2025 (Values in Cr)
    Net Income 21.52
    Cash from Operations 36.40
    Cash from Investing -30.70
    Cash from Financing -3.47
    Net change in Cash -0.15
    Free Cash Flow 68.68
    Particulars MAR 2024 (Values in Cr)
    Net Income 15.89
    Cash from Operations 141.82
    Cash from Investing -51.53
    Cash from Financing 27.44
    Net change in Cash 0.37
    Free Cash Flow 201.38
    Particulars MAR 2023 (Values in Cr)
    Net Income 16.87
    Cash from Operations 37.60
    Cash from Investing -74.37
    Cash from Financing 41.09
    Net change in Cash 0.06
    Free Cash Flow 119.80
    Particulars MAR 2022 (Values in Cr)
    Net Income 19.00
    Cash from Operations 35.52
    Cash from Investing -90.37
    Cash from Financing 54.62
    Net change in Cash -0.05
    Free Cash Flow 133.05
    Particulars MAR 2021 (Values in Cr)
    Net Income 13.23
    Cash from Operations 15.30
    Cash from Investing -46.83
    Cash from Financing 32.03
    Net change in Cash -0.22
    Free Cash Flow 62.13
    Particulars MAR 2025 (Values in Cr)
    Net Income 21.52
    Cash from Operations 36.40
    Cash from Investing -30.70
    Cash from Financing -3.47
    Net change in Cash -0.15
    Free Cash Flow 68.68
    Particulars MAR 2024 (Values in Cr)
    Net Income 15.89
    Cash from Operations 27.61
    Cash from Investing -51.53
    Cash from Financing 27.44
    Net change in Cash 0.37
    Free Cash Flow 87.17
    Particulars MAR 2023 (Values in Cr)
    Net Income 16.87
    Cash from Operations 37.60
    Cash from Investing -74.37
    Cash from Financing 41.09
    Net change in Cash 0.06
    Free Cash Flow 119.80
    Particulars MAR 2022 (Values in Cr)
    Net Income 19.00
    Cash from Operations 35.59
    Cash from Investing -90.40
    Cash from Financing 54.56
    Net change in Cash -0.05
    Free Cash Flow 133.12
    Particulars MAR 2021 (Values in Cr)
    Net Income 13.24
    Cash from Operations 15.31
    Cash from Investing -46.83
    Cash from Financing 32.03
    Net change in Cash -0.21
    Free Cash Flow 62.14
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 43.10 17.88 2.08 330.29 23.12 45.50
    BLISS GVS PHARMA LTD. 505.05 40.66 4.49 5365.85 118.35 552.90
    CIPLA LTD 1450.00 32.73 3.40 117137.57 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 551.65 25.80 3.99 1623.56 256.40 564.50
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 43.10 30.14 5.55 330.29 23.12 45.50
    AMRUTAJAN HEALTH LTD 525.20 23.54 4.10 1518.39 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8091.60 105.74 23.17 20229.00 7630.00 9850.00
    BLISS GVS PHARMA LTD. 505.05 54.66 4.64 5365.85 118.35 552.90

    SAKAR HEALTHCARE LIMITED shareholding pattern

    Holding
    23.97%
    52.51%
    12.13%
    11.37%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    SAKAR HEALTHCARE LIMITED Technicals Summary

    919.95 3.28 redarrow
    red-green-graph indicator
    0 Bearish
    16 Bullish
    • 5 Days 890.90
    • 26 Days 855.90
    • 10 Days 877.80
    • 50 Days 817.40
    • 12 Days 874.40
    • 100 Days 733.30
    • 20 Days 863.60
    • 200 Days 617.50
    898.37 PIVOT
    First Support 872.33 First Resistance 916.73 Second Support 853.97 Second Resistance 942.77 Third Support 827.93 Third Resistance 961.13
    RSI 56.63 ADX 13.23 MACD 18.56 Williams % R -33.65 Commodity Channel Index (CCI) 60.12
    Date 2026-08-05 Week 55900.00 Same Day 54254.00 Month 66475.00
    1 Year 0.72 3 Year 0.80
    Over 1 Month
    6.67% down
    Over 1 Year
    162.74% down
    Over 3 Months
    41.45% down
    Over 3 Years
    36.98% down
    Over 6 Months
    104.87% down
    Over 5 Years
    36.83% down

    SAKAR HEALTHCARE LIMITED Corporate Actions

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Sakar Healthcare Ltd?

    Answer Field

    Sakar Healthcare Ltd share price is for NSE ₹ 919.70 & for BSE ₹ 0.00 as on Aug 06 2026 03:30 PM.

    What is the Market Cap of Sakar Healthcare Ltd Share?

    Answer Field

    The market cap of Sakar Healthcare Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Aug 06 2026 03:30 PM.

    What is the 52 Week High and Low of Sakar Healthcare Ltd?

    Answer Field

    The 52 Week High and Low of Sakar Healthcare Ltd for NSE is ₹ 960.00 and ₹ 311.00 and for BSE is ₹ 0.00 and ₹ 0.00.

    What is 1 year return for Sakar Healthcare Ltd?

    Answer Field

    The 1 year returns on the stock has been 162.74%.

    What is the P/E Ratio of Sakar Healthcare Ltd Share?

    Answer Field

    As on Aug 06 2026 03:30 PM the price-to-earnings (PE) ratio for Sakar Healthcare Ltd share is 54.91.

    What is the PB ratio of Sakar Healthcare Ltd Share?

    Answer Field

    As on Aug 06 2026 03:30 PM, the price-to-book (PB) ratio for Sakar Healthcare Ltd share is 145.86.

    How to Buy Sakar Healthcare Ltd Share?

    Answer Field

    You can trade in Sakar Healthcare Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Sakar Healthcare Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Sakar Healthcare Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Sakar Healthcare Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |